Pro Medicus announces second interim dividend

The Directors are pleased to announce a second interim dividend of 0.75c per share, fully franked. This dividend was declared to be paid prior to June 30 to provide shareholders with maximum franking credit value prior to the reduction in company taxation rates from 34% to 30% effective from July 1.

A decision on a final dividend will be announced following the end of the financial year when final results are determined.

KEY POINTS
- Fully Franked 2nd interim dividend of 0.75c per share
- Second half profit expected to be up 50% on first half
- Profit estimated to be up 20% from previous year
- Profit anticipated within 15% of prospectus forecast
- 26% of GPs signed up for Promedicus.net
- New product developments underway

MARKET UPDATE
Pro Medicus has experienced its most successful and profitable six months in the company's 18 year history. This has been against a backdrop of difficult market conditions due to the disturbance caused by market rationalisation of the diagnostic imaging sector.

As previously reported, the company has won four significant contracts to a value of $8 million including an exclusive $5 million, 3 year contract with Medical Imaging Australasia (MIA), Australia's largest diagnostic imaging provider. Installation of these orders is well underway. However the timing of these contracts, which all came in the fourth quarter, combined with a number of logistic issues beyond the company's control, has meant that a proportion of the revenue anticipated from these contracts will not be realised until the first quarter of FY2002.

Despite the above, profit in the second half is anticipated to be 50% greater than that of the first half with full year profit increasing by over 20% as compared to the previous financial year making 2001 the most successful year for the company to date.

As a result, the company estimates at this stage the full year profit result to be within 15% of the prospectus target.

The directors are also pleased to report the continued growth of the company's e-health offering Promedicus.net. To date over 26% of Australian GP's are signed up for the service with new registrations continuing to grow. A number of new development and planning projects are also underway that are anticipated to result in new product announcements scheduled for the coming twelve months.

We look forward to presenting the final results in our Annual Report and encourage shareholders to stay in touch through use of our investor email service which can be used by emailing to shareholders@promedicus.com.au.

Shareholder Information Share Registry
Computershare Investor Services Pty Limited
Level Twelve, 565 Bourke Street
Melbourne VIC 3000
Phone: +61 3 9615 5970

For further information, contact:
Dr Sam Hupert
Managing Director,
Pro Medicus Limited

Email: hupert@promedicus.com.au
Phone: +61 3 9429 8800
Facsimile: +61 3 9429 9544